MoneyWorks4Me

Norris Medicines informs about unaudited financial results

11 Nov 2022 Evaluate
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed that it enclosed Standalone Un-audited Financial Results of the Company for the Quarter ended on 30th September, 2022; Limited Review Report on Standalone Un-audited Financial Results for the quarter ended on 30th September, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1736.70
Dr. Reddys Labs. 1241.45
Cipla 1318.20
Lupin 1943.20
Zydus Lifesciences 1113.95
View more..